The importance of serum pyruvate kinase in neuromuscular diseases and carrier states
- 1 September 1979
- journal article
- research article
- Published by Wiley in Muscle & Nerve
- Vol. 2 (5) , 390-393
- https://doi.org/10.1002/mus.880020511
Abstract
Serum pyruvate kinase activity was measured in several myopathic and denervating illnesses as well as in 86 potential carriers of Duchenne dystrophy. These data showed that in potential Duchenne carriers, the serum pyruvate kinase assay is more sensitive in younger patients, especially those under 20 years of age.This publication has 9 references indexed in Scilit:
- Serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) in progressive muscular dystrophiesJournal of the Neurological Sciences, 1978
- Pyruvate kinase: Diagnostic value in neuromuscular diseaseClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Serum pyruvate kinase in carriers of duchenne muscular dystrophyClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Serum pyruvate kinase in carriers of duchenne muscular dystrophyJournal of the Neurological Sciences, 1977
- Serum pyruvate kinase in muscle disease and carrier statesNeurology, 1974
- Pyruvate kinase isoenzymes in progressive muscular dystrophy and in acute myocardial infarctionMetabolism, 1973
- [85] Pyruvate kinase: Clinical aspectsPublished by Elsevier ,1966
- The carrier state in muscular dystrophy of the Duchenne typeJAMA, 1965